GlassScriptPhysician profile
John J Halki
NPI 1750362323
$128,874.80
in general payments reported to CMS, 2019-2025
8 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $47K · 2021: $436 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $115,213.86 | 2019-2020 | |
| Si-Bone, INC. | $10,378.31 | 2019-2025 | |
| Orthofix Medical, INC. | $1,233.15 | 2019 | |
| Alphatec Spine, INC | $1,068.79 | 2020 | |
| Stimwave Technologies Incorporated | $653.29 | 2020-2021 | |
| Kahtnu Surgical, INC. | $162.76 | 2021 | |
| Nevro Corp. | $106.64 | 2019-2021 | |
| Wenzel Spine, INC. | $58.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Halki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.